Fig. 3: Changes in lipid classes in SNCAG209A cells and transgenic mice. | npj Parkinson's Disease

Fig. 3: Changes in lipid classes in SNCAG209A cells and transgenic mice.

From: Lipid level alteration in human and cellular models of alpha synuclein mutations

Fig. 3

a Elevations in diradylglycerol (DG), triradylglycerol (TG), monohexosylceramide (MhCer), and monosialodihexosylganglioside (GM3) classes in homogenates from SNCAG209A neuroblastoma cells versus control lines (n = 4 biological replicates ± SD each run in triplicates. *p < 0.05, t test); b heatmaps representing statistically significant changes [log (2) fold change mutant versus controls] in main classes of lipids in tissues from SNCAG209A transgenic mice versus tissues from SNCA transgenic and non-transgenic mice (n = 3 biological replicates each run in triplicates. Colored areas are p < 0.05. t test. CI 95%).

Back to article page